Clinical trials: Post-ERCP Adverse Events
Pancreatitis Biliary, Pancreatitis Acute Biliary
Indomethacin for Biliary ERCP Patients
This study is a randomized clinical trial evaluating the efficacy of rectal indomethacin in preventing post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis in patients undergoing biliary ERCP who have a history…
- Conditions
- Pancreatitis Biliary, Pancreatitis Acute Biliary, Pancreatitis, Post-ERCP Pancreatitis
- Trial name
- NCT07661498
- Testing
- indomethacin
- Where
- United States
- Volunteers
- 860 people
- Sponsor
- University of California, San Francisco
Healthy
Combination of Rectal Indomethacin and Pancreatic Duct Stenting Versus Indomethacin Alone in Preventing PEP
Rectal indomethacin and pancreatic duct (PD) stenting (PDS) are recommended for the prevention of post-ERCP pancreatitis (PEP). However, the effects of the combination of the two methods on preventing PEP are controversial.
- Trial name
- NCT04340687
- Testing
- Pancreatic duct stenting
- Where
- China
- Volunteers
- 664 people
- Sponsor
- Air Force Military Medical University, China
Stent Dislodgement, ERCP
Spontaneous Dislocation and Adverse Events of a Prophylactic Pancreatic Stent
A multicenter, prospective, controlled randomized study to investigate the optimal duration of protective pancreatic stents after endoscopic retrograde cholangiopancreatography (ERCP).
- Conditions
- Stent Dislodgement, ERCP, Pancreas Stent, Post-ERCP Pancreatitis
- Trial name
- SAFE PANCREAS (NCT07346365)
- Testing
- pancreatic stent removal, standard group
- Where
- Germany
- Volunteers
- 358 people
- Sponsor
- Johann Wolfgang Goethe University Hospital
Endoscopic Retrograde Cholangiopancreatography
Observational Study to Develop a Predictive Score for Adverse Events Post ERCP
The main objective of the study is: the identification of independent factors associated with an increased risk of post-ERCP complications.
- Trial name
- NCT06776874
- Where
- Italy
- Volunteers
- 981 people
- Sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
Post-ERCP Adverse Events, ERCP Complications
Factors for Prolonged Hospital Stays in Patients Undergoing ERCP
Endoscopic retrograde cholangiopancreatography (ERCP) is a crucial minimally invasive technique for the diagnosis and treatment of biliary and pancreatic diseases.
- Trial name
- NCT07568626
- Where
- 5 sites in China
- Volunteers
- 504 people
- Sponsor
- Air Force Military Medical University, China
Post-ERCP Acute Pancreatitis, Cholangitis
ERCP in Super-aged Patients Considering Difficult Cannulation: Challenges and Adverse Events
Today 11 percent of China's population is over the age of 65, and according to United Nations, it will take China just 20 years for the proportion of the elderly population to double to 25%.
- Trial name
- NCT03771547
- Testing
- ERCP
- Where
- China
- Volunteers
- 614 people
- Sponsor
- The Second Hospital of Nanjing Medical University